Literature DB >> 16580585

In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits.

Haralabos C Karantonis1, Smaragdi Antonopoulou, Despina N Perrea, Dimitrios P Sokolis, Stamatios E Theocharis, Nikolaos Kavantzas, Dimitrios G Iliopoulos, Constantinos A Demopoulos.   

Abstract

BACKGROUND AND AIM: The consumption of olive oil has been associated with lower incidence of cardiovascular disease in the Mediterranean countries. This may be due in part to the action of platelet-activating factor (PAF) antagonists which we have previously demonstrated to be present in olive oil. In order to assess the in vivo effects of olive oil lipids and PAF in the development of atherosclerosis, the effects of diet supplementation with olive oil (OO), olive oil polar lipid extract (OOPLE) and olive oil neutral lipid extract (OONLE) were studied in rabbits fed a cholesterol-enriched diet. METHODS AND
RESULTS: Rabbits were fed for 45 days with atherogenic diet (Group A) supplemented with OO (Group B), OOPLE (Group C) or OONLE (Group D). Lipoprotein profiles, plasma in vitro oxidation, blood PAF levels, PAF-induced platelet aggregation and PAF-acetylhydrolase (PAF-AH) activity, were measured on day 0 and 45. Atherosclerotic lesions formed in the aortic wall and wall elasticity were assessed on day 45. Changes in lipid profile were in accordance with previous studies. Blood PAF levels were higher in group A and decreased in group D on day 45. In rabbits fed an atherogenic diet (Group A) blood PAF and PAF-AH increased, atherosclerotic lesions formed and the elasticity of vessel walls declined. In animals fed olive oil (Group B) or OOPLE (Group C) blood PAF-AH increased, platelet aggregation was attenuated, less oxidation occurred in plasma, lesion thickness was reduced and vessel walls retained elasticity. Most of these beneficial changes were not seen in animals fed OONLE (Group D) although blood PAF and plasma oxidation were lower.
CONCLUSIONS: The antiatherogenic effects of OO result from OOPLE. The beneficial effect of these factors is linked to PAF metabolism and proaggregant activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16580585     DOI: 10.1016/j.numecd.2005.07.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  18 in total

1.  The relation of diet with PAF and its metabolic enzymes in healthy volunteers.

Authors:  P Detopoulou; E Fragopoulou; T Nomikos; M Yannakoulia; G Stamatakis; D B Panagiotakos; S Antonopoulou
Journal:  Eur J Nutr       Date:  2014-03-18       Impact factor: 5.614

2.  Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.

Authors:  Nibrass Taher Abdali; Awny H Yaseen; Eman Said; Tarek M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-18       Impact factor: 3.000

Review 3.  The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

Review 4.  Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.

Authors:  Paraskevi Detopoulou; Tzortzis Nomikos; Elizabeth Fragopoulou; Christina Chrysohoou; Smaragdi Antonopoulou
Journal:  Curr Heart Fail Rep       Date:  2013-06

5.  Hypolipidemic and antioxidant effects of dandelion (Taraxacum officinale) root and leaf on cholesterol-fed rabbits.

Authors:  Ung-Kyu Choi; Ok-Hwan Lee; Joo Hyuk Yim; Chang-Won Cho; Young Kyung Rhee; Seong-Il Lim; Young-Chan Kim
Journal:  Int J Mol Sci       Date:  2010-01-06       Impact factor: 6.208

6.  Comparative antilipidemic effect of N-acetylcysteine and sesame oil administration in diet-induced hypercholesterolemic mice.

Authors:  Laskarina-Maria Korou; George Agrogiannis; Alkisti Pantopoulou; Ioannis S Vlachos; Dimitrios Iliopoulos; Theodoros Karatzas; Despoina N Perrea
Journal:  Lipids Health Dis       Date:  2010-03-06       Impact factor: 3.876

7.  Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis.

Authors:  Haralabos C Karantonis; Georgios Gribilas; Ioannis Stamoulis; Constantinos Giaginis; Chara Spiliopoulou; Gregorios Kouraklis; Constantinos Demopoulos; Stamatios E Theocharis
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

8.  Platelet activating factor levels and metabolism in Tangier disease: a case study.

Authors:  Vana Kolovou; Vasiliki D Papakonstantinou; George Stamatakis; Sophia N Verouti; Marianna N Xanthopoulou; Genovefa Kolovou; Constantinos A Demopoulos
Journal:  Lipids Health Dis       Date:  2012-07-08       Impact factor: 3.876

9.  Differential effect of Pistacia vera extracts on experimental atherosclerosis in the rabbit animal model: an experimental study.

Authors:  Katerina A Marinou; Katerina Georgopoulou; George Agrogiannis; Theodore Karatzas; Dimitrios Iliopoulos; Apostolos Papalois; Achilles Chatziioannou; Prokopios Magiatis; Maria Halabalaki; Nektaria Tsantila; Leandros A Skaltsounis; Efstratios Patsouris; Ismene A Dontas
Journal:  Lipids Health Dis       Date:  2010-07-16       Impact factor: 3.876

10.  Characterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cells.

Authors:  Alexandros Basilios Tsoupras; Elizabeth Fragopoulou; Tzortzis Nomikos; Christos Iatrou; Smaragdi Antonopoulou; Constantinos Alexandros Demopoulos
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.